NX
Nexien BioPharma, Inc.
NXEN · OTC
$0.00 +0.00% (+$0.00)
Market Cap $7.08K
P/E Ratio -
Div. Yield -
ROE -
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
1/9Valuation
-
N/A P/E N/A
PEG N/A
EV/EBITDA N/A
Growth
-
N/A EPS growth N/A
Book val. growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
57 /100
Average ROIC 157.47%
Asset turnover 0.00x
ROA 2,270.15%
Debt
0 /100
High Current ratio 0.02x
Int. coverage -1.70x
Debt/Equity N/A
Stability
61 /100
Moderate Beta -0.88x
Profitable years 0
EPS volatility 15.44%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about NXEN
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Richard S. Greenberg
Employees
10
Headquarters
Glendale